MedTrace Logo

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

NCT01842100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2193

Last updated 2013-04-29

No results posted yet for this study

Summary

Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.

Conditions

  • Induced Abortion
  • Postaboral Pelvic Inflammatory Disease
  • Sexually Transmitted Infections

Interventions

DRUG

Universal antibiotic prophylaxis

100 mg twice daily for 7 days starting on the day of induced abortion

OTHER

Screen-and-treat

Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Sofie SF Yung, MBBS, MRCOG · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2006-02-28
Completion
2006-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01842100 on ClinicalTrials.gov